TrialArthritis & rheumatology (Hoboken, N.J.)2014
Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis.
E M Miloslavsky et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this paperpooled ittrialcites it